PMI Korea Launches “Sentia” Pod for IQOS ILUMA

Apr.01
PMI Korea Launches “Sentia” Pod for IQOS ILUMA
PMI launches "Sentia" pods for IQOS ILUMA in South Korea, targeting new users, available nationwide from March 3.

Key points:

  • PMI Korea has launched a new pod called "Sentia" specifically designed for IQOS ILUMA, which will be available nationwide starting on March 3rd.
  • "Sentia" comes in four flavors, designed specifically for beginners to help transition to heated tobacco products.
  • This new product is being sold at 9 company-owned stores and major convenience stores, and is produced at the Yangsan, Gyeongnam.

According to N.News on April 1st, PMI Korea announced that they will begin nationwide sales of the "Sentia" pods customized for the "IQOS ILUMA" series starting from the 3rd. This new product is designed specifically for adult smokers trying IQOS for the first time.

 

The "Sentia" series consists of four flavors: Sentia Classic Gold, Classic Silver, Classic Purple and Classic Green. These products will be available for sale at 9 IQOS flagship stores nationwide and major convenience stores including those in Seoul and Gyeonggi Province starting from the day of their launch.

 

"Sentia" is produced and supplied by PMI's factory located in Yangsan, Gyeongnam. Similar to TEREA, the production of "Sentia" is based on the same equipment and quality standards.

 

The company representative stated that,

 

"Sentia provides more options for users of the IQOS ILUMA series, helping adult smokers who are considering switching from traditional cigarettes to heated tobacco products to start using IQOS ILUMA at a lower cost."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
2Firsts received a legal commentary from lawyer Zheng Mingwei’s team, analyzing the FDA’s approval of JUUL menthol e-cigarettes. The article outlines key scientific data, regulatory standards, and industry implications.
Jul.22
WHO urges Germany to raise tobacco tax to curb consumption
WHO urges Germany to raise tobacco tax to curb consumption
WHO calls on Germany to significantly increase tobacco tax to limit consumption, while EU plans reform on tobacco tax.
Jun.26 by 2FIRSTS.ai
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Since April 2024, Singapore’s Health Sciences Authority (HSA) has shut down over 600 Telegram groups promoting or selling e-cigarettes and Kpods. This is the first time HSA has released such data. Additionally, from January 2024 to March 2025, HSA and the Ministry of Health removed more than 6,800 online listings related to e-cigarettes—more than double the number removed in 2023.
Jul.17 by 2FIRSTS.ai
Product | Brands Like Off-Stamp and SKE Launch Clear-Tank E-Cigarettes in UK and US Markets
Product | Brands Like Off-Stamp and SKE Launch Clear-Tank E-Cigarettes in UK and US Markets
Several new e-cigarette products featuring clear-tank designs have recently entered the market, including the Off-Stamp X Cube Crystal Cube 35K in the U.S. and the SKE Crystal Edge X in the UK. These models offer increased puff counts and e-liquid capacity, with the transparent tank as a key design highlight.
Jul.30 by 2FIRSTS.ai
KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand
KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand
KT&G subsidiary Taeya Industry booked heavy impairment losses after overinvesting in capacity based on inaccurate demand forecasts. Although KT&G aims to offset the damage through global value-chain expansion, Taeya’s financial health remains severely strained, and the company is now devising new export programs to utilize its idle facilities.
Jul.15 by 2FIRSTS.ai
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. tobacco maker Cabbacis has secured a USPTO patent (No. 12,349,724) for oral vaporizer pods, effective until July 2038. With existing patents, its iBlend™ harm-reduction products—featuring low-nicotine and hemp blends—are now protected in over 30 countries and key global tobacco markets.
Jul.18 by 2FIRSTS.ai